Like breast or prostate cancers that show elevated SENP1 expression, our tissue microarray (TMA) analysis found that high SENP1 expression combined with high HIF2α expression showed a poor overall survival of ccRCC patients. This evidence concerns the gene SENP1 and prostate cancer.